Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya

Summary

This clinical trial develops and studies how well mobile health (m-Health) patient navigation (PN) strategies work to improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya. Although highly curable, breast cancer kills thousands of women in developing countries yearly. Mammography (MMG) is used for the early detection of breast cancer by creating a picture of the breast using film or a computer. Despite the availability of MMG in all 47 counties in Kenya, screening remains low in eligible women. Early detection of breast cancer may also be improved through access to high quality clinical breast exams (CBE). However, primary care providers in Kenya face barriers to incorporating CBE into practice, including limited patient awareness of breast cancer screening. m-Health uses applications on mobile phones to deliver PN directly to the patients. The PN strategies in this study include digital platforms and tools to help with education, reminders, navigation, and motivation around breast cancer screening. This may improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya.

Conditions

• Breast Carcinoma

Interventions

OTHER

Best Practice

Receive EUC

OTHER

Discussion

Complete a focus group

OTHER

Interview - Stakeholder

Complete stakeholder interview

OTHER

Interview - Key Informant

Complete key informant interview

OTHER

Interview - Ancillary studies

Ancillary studies

BEHAVIORAL

Patient Navigation - C Components

Receive adapted m-Health PN strategy C components

BEHAVIORAL

Patient Navigation - B components

Receive adapted m-Health PN strategy B components

BEHAVIORAL

Patient Navigation - A components

Receive adapted m-Health PN strategy A components

OTHER

Survey Administration

Complete EBI adaptation and implementation surveys

OTHER

Survey Administration - Ancillary studies

Ancillary studies

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• Emory University

  lead OTHER

Principal Investigators

• Michael Chung · Emory University Hospital/Winship Cancer Institute

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

SINGLE

Model

SEQUENTIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2025-07-22

Primary Completion

2028-06-30

Completion

2029-06-30

Countries

• United States

Study Locations